Your browser doesn't support javascript.
loading
Detecting Disruption of HER2 Membrane Protein Organization in Cell Membranes with Nanoscale Precision.
Moradi, Yasaman; Lee, Jerry S H; Armani, Andrea M.
Affiliation
  • Moradi Y; Mork Family Department of Chemical Engineering and Materials Science, University of Southern California, Los Angeles, California 90089, United States.
  • Lee JSH; Ellison Institute of Technology, Los Angeles, California 90064, United States.
  • Armani AM; Mork Family Department of Chemical Engineering and Materials Science, University of Southern California, Los Angeles, California 90089, United States.
ACS Sens ; 9(1): 52-61, 2024 Jan 26.
Article in En | MEDLINE | ID: mdl-37955934
ABSTRACT
The spatiotemporal organization of proteins within the cell membrane can affect numerous biological functions, including cell signaling, communication, and transportation. Deviations from normal spatial arrangements have been observed in various diseases, and a better understanding of this process is a key stepping stone to advancing development of clinical interventions. However, given the nanometer length scales involved, detecting these subtle changes has primarily relied on complex super-resolution and single-molecule imaging methods. In this work, we demonstrate an alternative fluorescent imaging strategy for detecting protein organization based on a material that exhibits a unique photophysical behavior known as aggregation-induced emission (AIE). Organic AIE molecules have an increase in emission signal when they are in close proximity, and the molecular motion is restricted. This property simultaneously addresses the high background noise and low detection signal that limit conventional widefield fluorescent imaging. To demonstrate the potential of this approach, the fluorescent molecule sensor is conjugated to a human epidermal growth factor receptor 2 (HER2)-specific antibody and used to investigate the spatiotemporal behavior of HER2 clustering in the membrane of HER2-overexpressing breast cancer cells. Notably, the disruption of HER2 clusters in response to an FDA-approved monoclonal antibody therapeutic (Trastuzumab) is successfully detected using a simple widefield fluorescent microscope. While the sensor demonstrated here is optimized for sensing HER2 clustering, it is an easily adaptable platform. Moreover, given the compatibility with widefield imaging, the system has the potential to be used with high-throughput imaging techniques, accelerating investigations into membrane protein spatiotemporal organization.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Breast Neoplasms / Membrane Proteins Limits: Female / Humans Language: En Journal: ACS Sens Year: 2024 Type: Article Affiliation country: United States

Full text: 1 Database: MEDLINE Main subject: Breast Neoplasms / Membrane Proteins Limits: Female / Humans Language: En Journal: ACS Sens Year: 2024 Type: Article Affiliation country: United States